Physicians Brace for Drug, Device 'Transparency'
Prior efforts to increase disclosure of industry-physicians financial relationship include a 2009 Institute of Medicine report, that developed recommendations "to identify, limit and manage without affecting constructive collaborations with industry and called for broad public transparency," according to the NEJE report.
The Physician Payment Sunshine Act was created by Congress to ensure transparency in physicians' interactions with the pharmaceutical, biologic and medical device industries as well as group purchasing organizations.
The law covers meals, honoraria, travel expenses, and grants from manufacturers, and ownership and investment interests by physicians or members of their immediate family. Eventually, physicians who have received payments or hold ownership will be posted on a website, under the National Physician Payment Transparency Program of the CMS.
The AMA is offering doctors a Physician Sunshine Act Tool Kit to help navigate the changes.
Joe Cantlupe is a senior editor with HealthLeaders Media Online.
- No Employee Satisfaction, No Patient-Centered Culture
- RN Named Chief Patient Experience Officer
- As Retail Clinics Surge, Quality Metrics MIA
- Providers' Push to Consolidate Roils Payers
- Medicare Cost, Quality Data Tools Weak, Says GAO
- Population Health Pays Off for NY Collaborative
- How Payers Are Curbing Behavioral-Health Cost Drivers
- Medicare to Finally Pay Doctors for Care They Were Giving Away
- Former NQF Co-Chair Linked to Conflicts of Interest in Journal Probe
- AMA Pushes Lame Duck Congress for SGR Repeal